158 results on '"Clavien, Pierre A."'
Search Results
2. Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
3. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation
4. TOP-559 Metabolic needs dictate the regenerative capacity of the liver
5. TOP-140 Evolution of clinical presentation, treatment and prognosis of patients with alveolar echinococcosis treated at the university hospital Zurich: a 50-year experience
6. The essential requirements for an HPB centre to deliver high-quality outcomes
7. Reply to: “Patients with hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation: A meta-analysis”
8. Allocation of liver grafts worldwide – Is there a best system?
9. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation
10. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
11. JNK1 induces hedgehog signaling from stellate cells to accelerate liver regeneration in mice
12. Surgical resection for intrahepatic cholangiocarcinoma – can we really improve survival by resecting more lymph nodes?
13. A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation
14. When is steatosis too much for transplantation?
15. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma
16. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice
17. Do we need a center approach to treat patients with liver diseases?
18. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis
19. Perioperative omega-3 fatty acids fail to confer protection in liver surgery: Results of a multicentric, double-blind, randomized controlled trial
20. Reply to: “Canadian liver transplant allocation for hepatocellular carcinoma”
21. Allocation of liver grafts worldwide – Is there a best system?
22. Should living donor liver transplantation be part of every liver transplant program?
23. Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver
24. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism
25. PS-168-Novel real time prediction of liver graft function during hypothermic oxygenated machine perfusion prior to liver transplantation
26. Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?
27. Potentially inappropriate liver transplantation in the era of the “sickest first” policy – A search for the upper limits
28. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans
29. Reply to: “The rescue of DCD rodent livers grafts: Is there HOPE?”
30. Hedgehog pathway mediates early acceleration of liver regeneration induced by a novel two-staged hepatectomy in mice
31. Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss
32. Reply to ‘Is single portal vein perfusion the best approach for machine preservation of liver grafts?’
33. Warm vs. cold perfusion techniques to rescue rodent liver grafts
34. Fasting protects liver from ischemic injury through Sirt1-mediated downregulation of circulating HMGB1 in mice
35. HOPE for human liver grafts obtained from donors after cardiac death
36. GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids
37. Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation
38. Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts
39. Liver transplantation for unresectable hepatocellular carcinoma in normal livers
40. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A2
41. Liver transplantation using fatty livers: Always feasible?
42. Inhibition of mammalian target of rapamycin: Two goals with one shot?
43. Requiem for a champion? Living donor liver transplantation
44. Who should get a liver graft?
45. Liver transplantation for pregnancy-related liver diseases, pregnancy and sexual function after liver transplantation: What do we know?
46. Tenth Forum on Liver Transplantation
47. Hot topics in liver transplantation: Organ allocation – extended criteria donor – living donor liver transplantation
48. Omega 3 – Omega 6: What is right for the liver?
49. Is there a place for Liver Transplantation for “non HCC” tumors?
50. Acute liver failure: Where are the challenges?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.